Home / HNSA.ST : STO

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does HNSA.ST make money? Does HNSA.ST have pricing power? What's the Earnings Whisper? Will HNSA.ST profit more as the business scales? What is HNSA.ST's management track record? Is HNSA.ST's current price justified?

Hansa Biopharma AB (publ)

SEK 39.34 +$6.64 (+20.31%)

STO · 30 Oct 2026 11:59 UTC

Previous Close

SEK 39.34

Day Range

SEK 39.04SEK 40.00

Year Range

SEK 23.52SEK 48.22

Market Cap

3.92B

AVG Volume

595.63K

Trailing/Forward PE

-5.01/-

PEG ratio

0.05

Dividend Yield

Next Earnings Date

2026-11-11

Primary Exchange

Stockholm Stock Exchange

Revenue (SEK) · A

HNSA.ST Revenue (SEK) by year
Period	Revenue (SEK)
2025	222.26M
2024	171.32M
2023	134.09M
2022	154.53M
2021	33.88M
2020	6.1M
2019	3.36M
2018	3.36M
2017	3.44M
2016	2.58M

Net Income (SEK) · A

HNSA.ST Net Income (SEK) by year
Period	Net Income (SEK)
2025	-529.25M
2024	-806.74M
2023	-831.72M
2022	-611.13M
2021	-548.28M
2020	-420.85M
2019	-360.01M
2018	-247.97M
2017	-176.66M
2016	-111.13M

Operating Income (SEK) · A

HNSA.ST Operating Income (SEK) by year
Period	Operating Income (SEK)
2025	-520.99M
2024	-595.14M
2023	-794.91M
2022	-595.3M
2021	-546.98M
2020	-422.81M
2019	-359.67M
2018	-246.5M
2017	-176.08M
2016	-111.14M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (SEK) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Hansa Biopharma AB (publ)

Earnings: HNSA.ST

Video analysis: HNSA.ST

News: HNSA.ST

Similar companies